Short communication · May 2021
Research articlePublished 2018
Pranlukast; An Alternative Potential Leptin Stimulator: Structure-Based Virtual Screening Study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Leptin is secreted by adipocytes, transported into the brain and binds to its receptor in the hypothalamus, and activates JAK-STAT3, leading to increase in “anorexigenic peptides” which normally inhibit food consumption and reduce weight.Objectives: In the current study, a hybrid approach of molecular docking and virtual screening was performed, for the identification of active alternative compounds to manage obesity disorders.Methods: Screening was performed using structure-based drug design against approved FDA drugs; molecular modeling was done using AutoDockVina; only top 10 conformers’ ligands with highest and best scores were selected. In order to increase the likelihood of successful docking, in silico Virtual Screening (VS) of selected compounds were filtered according to their molecular weight and partition coefficient; a molecular weight of less than 500 and a partitioning coefficient (log P) of less than 5 filtering is applied.Result: Here, we report the screening of four compounds that have showed maximum binding affinity against Leptin receptor, obtained through the ZINC database. A VS approach coupled with docking energies illustrated that Pranlukast could be potential stimulator compounds for targeting Leptin receptor.Conclusion: We proposed that Pranlukast may be more potent Leptin receptor stimulator analogue based on the binding energy values. Further work can be extended to study the receptor ligand interactions experimentally and evaluation of their biological activity would help in designing novel therapeutic lead for the management of obesity disorders.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2018
The search for potential isoform-selective histone deacetylase inhibitors via structure-based virtual screening
Conference abstract · 24 Oct 2022
Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinas inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking and molecular dyn
Research article · 2016
Structure-Based Pharmacophore Modeling, Virtual Screening and Molecular docking for the Treatment of ESR1 Mutations in Breast Cancer
Conference abstract · 24 Oct 2022
Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinas inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking and molecular dynamics simulation
More from this journal
The newest in Immunochemistry & Immunopathology.
Commentary · 29 Dec 2025
Advancements In Immunoassay Technologies For Diagnostics And Discovery
Short communication · 29 Dec 2025
Targeting Immune Pathways for Autoimmune Disease
Short communication · 29 Dec 2025
Immune Biomarkers: Precision Diagnostics and Personalized Therapies
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImmunochemistry & Immunopathology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Mazin Yousif Babiker Alsafi”
- BylineArticles whose byline prints “Deyaa EldinTaha Manalla”
- BylineArticles whose byline prints “Islam Adil Abdulrahman”
- BylineArticles whose byline prints “Omar Hashim Ahmed”
- BylineArticles whose byline prints “Tarig El-Hadiyah”

